Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexicon Pharmaceuticals (LXRX) Preferred Shares Issued (2024)

Lexicon Pharmaceuticals (LXRX) has disclosed Preferred Shares Issued for 1 consecutive years, with -$78000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Preferred Shares Issued changed N/A to -$78000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was -$78000.0, a 100.03% decrease, with the full-year FY2024 number at $241.3 million, changed N/A from a year prior.
  • Preferred Shares Issued was -$78000.0 for Q4 2024 at Lexicon Pharmaceuticals, down from -$10000.0 in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $241.4 million in Q1 2024 to a low of -$78000.0 in Q4 2024.